UNSPSC 51373402: Acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373402 Acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine (Commodity) identifies pharmaceutical products and related clinical services that state and local health and corrections agencies buy to support incarcerated populations and community health initiatives. Recent solicitations show state and local governments purchasing parenteral nutrition solutions, intravenous products, naloxone, and drug deactivation systems through standing contracts with multiple-vendor award structures and stringent delivery and insurance requirements. The issuing bodies are primarily state corrections departments and county health authorities. The Washington State Department of Corrections and Seminole County, Florida represent the recent buyer base; both solicitations emphasize rapid turnaround, documented clinical capability, and compliance with state licensing and background-clearance standards.

The code shows recent activity in Washington state and Florida. The Washington State Department of Corrections posted RFQ RFQQK13020 on September 8, 2026, with a response deadline of October 7, 2026, for parenteral products and services across eight correctional facilities, with the contract term running from November 26, 2026 through June 30, 2030 and discretionary extension rights retained; DOC anticipates awarding up to three bidders per region and requires parenteral nutrition bags delivered within 24 hours and other parenteral products within 8 hours. Seminole County, Florida posted IFB 60459723LAS seeking 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries, though the opportunity shows a posted date of June 30, 2026 and a due date that appears inconsistent with the posting timeline. Both solicitations require specific insurance coverage, compliance with state business licensing, and drug-free workplace certification; the Washington solicitation includes aspirational small and diverse business goals (25% small business, 10% minority-owned, 6% women-owned, 5% veteran-owned participation).